Honors & Awards

  • A*STAR National Science Scholarship (PhD), Agency for Science, Technology & Research (A*STAR) (June 2019)
  • EMBO/SCSS Conference Travel Award, European Molecular Biology Organization, Singapore Stem Cell Society Singapore (September 2018)
  • Development, Regeneration and Stem Cell Biology Honours Class Prize, The University of Edinburgh (November 2017)
  • Duke of Edinburgh's International Award, National Youth Achievement Award Council (October 2014)
  • A*STAR National Science Scholarship (Bachelor of Science), Agency for Science, Technology & Research (A*STAR) (July 2013)
  • Academic Award for Outstanding Performance Academic Year 2012/2013, Singapore Polytechnic (April 2013)
  • A*STAR Science Award (Polytechnic), Agency for Science, Technology & Research (A*STAR) (November 2012)

Membership Organizations

Education & Certifications

  • BSc (Hons) 1st Class, The University of Edinburgh, Development, Regeneration, and Stem Cell Biology (2018)
  • Diploma (Distinction), Singapore Polytechnic, Biotechnology (2013)

All Publications

  • Human Finger-Prick Induced Pluripotent Stem Cells Facilitate the Development of Stem Cell Banking STEM CELLS TRANSLATIONAL MEDICINE Tan, H., Toh, C., Ma, D., Yang, B., Liu, T., Lu, J., Wong, C., Tan, T., Li, H., Syn, C., Tan, E., Lim, B., Lim, Y., Cook, S. A., Loh, Y. 2014; 3 (5): 586–98


    Induced pluripotent stem cells (iPSCs) derived from somatic cells of patients can be a good model for studying human diseases and for future therapeutic regenerative medicine. Current initiatives to establish human iPSC (hiPSC) banking face challenges in recruiting large numbers of donors with diverse diseased, genetic, and phenotypic representations. In this study, we describe the efficient derivation of transgene-free hiPSCs from human finger-prick blood. Finger-prick sample collection can be performed on a "do-it-yourself" basis by donors and sent to the hiPSC facility for reprogramming. We show that single-drop volumes of finger-prick samples are sufficient for performing cellular reprogramming, DNA sequencing, and blood serotyping in parallel. Our novel strategy has the potential to facilitate the development of large-scale hiPSC banking worldwide.

    View details for DOI 10.5966/sctm.2013-0195

    View details for Web of Science ID 000335939000015

    View details for PubMedID 24646489

    View details for PubMedCentralID PMC4006490